<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>
<channel>
	<title>Medical Product Guide&#187; SABCS</title>
	<atom:link href="http://blog.medicalproductguide.com/tag/sabcs/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.medicalproductguide.com</link>
	<description>A comprehensive guide to medical products for medical professionals</description>
	<lastBuildDate>Mon, 20 Jun 2011 12:36:09 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.3</generator>
		<item>
		<title>Switching To Letrozole Helps Breast Cancer Patients With Anastrozole-Related Rheumatologic Symptoms</title>
		<link>http://blog.medicalproductguide.com/2010/01/04/switching-letrozole-helps-breast-cancer-patients-anastrozolerelated-rheumatologic-symptoms/</link>
		<comments>http://blog.medicalproductguide.com/2010/01/04/switching-letrozole-helps-breast-cancer-patients-anastrozolerelated-rheumatologic-symptoms/#comments</comments>
		<pubDate>Mon, 04 Jan 2010 11:56:17 +0000</pubDate>
		<dc:creator>Jim Marino</dc:creator>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[anastrozole]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[Postmenopausal]]></category>
		<category><![CDATA[SABCS]]></category>
		<guid isPermaLink="false">http://www.medicalproductguide.com/blog/?p=391</guid>
		<description><![CDATA[Postmenopausal women with hormone receptor-positive (HR+) breast cancer who develop arthralgia and/or myalgia (A/M) while being treated with anastrozole may want to consider a switch to letrozole therapy, researchers said at the 32nd Annual San Antonio Breast Cancer Symposium (SABCS). Women who experienced greater than equal to grade 2 A/M while receiving anastrozole and switched [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://blog.medicalproductguide.com/files/2010/01/Annual-San-Antonio-Breast-Cancer-Symposium3.png"><img class="alignright size-full wp-image-399" style="margin: 5px" src="http://blog.medicalproductguide.com/files/2010/01/Annual-San-Antonio-Breast-Cancer-Symposium3.png" border="0" alt="Annual San Antonio Breast Cancer Symposium" width="200" height="117" /></a>Postmenopausal women with hormone receptor-positive (HR+) breast cancer who develop arthralgia and/or myalgia (A/M) while being treated with anastrozole may want to consider a switch to letrozole therapy, researchers said at the 32nd Annual San Antonio Breast Cancer Symposium (SABCS). Women who experienced greater than equal to grade 2 A/M while receiving anastrozole and switched to letrozole developed significantly less A/M and had an improved quality of life compared with baseline.</p>
<p>For the full story, <a href="http://www.medicalnewstoday.com/articles/174943.php" target="_blank">Click Here</a></p>
]]></content:encoded>
			<wfw:commentRss>http://blog.medicalproductguide.com/2010/01/04/switching-letrozole-helps-breast-cancer-patients-anastrozolerelated-rheumatologic-symptoms/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

<!-- Performance optimized by W3 Total Cache. Learn more: http://www.w3-edge.com/wordpress-plugins/

Served from: blog.medicalproductguide.com @ 2012-02-07 10:59:15 -->
